These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 1476754)

  • 61. IgA, glomerulonephritis and liver disease.
    Woodroffe AJ
    Aust N Z J Med; 1981; 11(Suppl 1):109-11. PubMed ID: 6942798
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Multiple serum markers in patients with endometrial cancer.
    Panici PB; Scambia G; Baiocchi G; Perrone L; Greggi S; Battaglia F; Mancuso S
    Gynecol Obstet Invest; 1989; 27(4):208-12. PubMed ID: 2744625
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Markedly elevated CA125 in hepatic cirrhosis: two case illustrations and review of the literature.
    DiBaise JK; Donovan JP
    J Clin Gastroenterol; 1999 Mar; 28(2):159-61. PubMed ID: 10078827
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Diagnostic usefulness and limitation of measuring pancreatic cancer associate antigen, SPan-1, in patients with pancreatic cancer].
    Satake K; Chung YS; Umeyama K; Takeuchi T; Kim YS
    Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-1):1139-46. PubMed ID: 2730018
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Autoimmune phenomena in alcholic cirrhosis.
    Zinneman HH
    Am J Dig Dis; 1975 Apr; 20(4):337-45. PubMed ID: 1093390
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [The pre- and postoperative monitoring of the immunological indices and tumor markers in colorectal carcinoma].
    Iarŭmov N; Ignatov A; Viiachki I
    Khirurgiia (Sofiia); 1998; 51(3):42-8. PubMed ID: 9974027
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Clinical significance and prognostic value of CA72-4 compared with CEA and CA19-9 in patients with gastric cancer.
    Ychou M; Duffour J; Kramar A; Gourgou S; Grenier J
    Dis Markers; 2000; 16(3-4):105-10. PubMed ID: 11381189
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Non-specific increase of serum carbohydrate antigen 19-9 in patients with liver disease associated with increased circulating levels of adhesion molecules.
    Fabris C; Falleti E; Pirisi M; Soardo G; Toniutto P; Vitulli D; Bortolotti N; Gonano F; Bartoli E
    Clin Chim Acta; 1995 Dec; 243(1):25-33. PubMed ID: 8747511
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Comparison of tumour markers TAG 12 with CA 15-3 and MCA in breast cancer diagnosis.
    Eskelinen M; Hippelainen M; Salmela E; Paajanen H; Carlsson L; Jonsson P; Alhava E
    Anticancer Res; 1992; 12(1):39-42. PubMed ID: 1567179
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Serum IgE levels in liver cirrhosis. Contrasting results in alcoholic and non-alcoholic patients.
    Vidal C; Quintela AG; Millán I; Gude F; Cuervas-Mons V
    Clin Exp Allergy; 1994 Jun; 24(6):540-8. PubMed ID: 7922775
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Correlation of caffeine elimination and Child's classification in liver cirrhosis.
    Holstege A; Staiger M; Haag K; Gerok W
    Klin Wochenschr; 1989 Jan; 67(1):6-15. PubMed ID: 2921843
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Serum levels of immunoglobulins IgG, IgA and transferin and importance of the ratio IgA-transferin in patients with liver diseases (author's transl)].
    Kratochvil F; Horecká J
    Cesk Gastroenterol Vyz; 1973 Oct; 27(7):448-53. PubMed ID: 4760007
    [No Abstract]   [Full Text] [Related]  

  • 73. Cancer-associated antigen CA 15-3 in the diagnostics of breast tumours.
    Eskelinen M; Tikanoja S; Valkamo E; Loikkanen M; Collan Y
    Scand J Clin Lab Invest; 1988 Nov; 48(7):653-8. PubMed ID: 3201097
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Serum IgA antibodies to human gut luminal aspirates and human liver in alcoholic liver disease.
    Douds AC; Lewis DJ; Lim AG; Maxwell JD; Poulton TA
    Alcohol Clin Exp Res; 1998 Oct; 22(7):1383-8. PubMed ID: 9802516
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Pretreatment concentrations of breast carcinoma antigen (CA 15.3) and mucin-like carcinoma-associated antigen in patients with carcinoma of the breast.
    Góźdź SS; Kowalska MM; Słuszniak JT; Słuszniak A; Korejba W; Bukowski J; Banasińska E; al-Jazzaf H; Szymendera JJ
    Tumour Biol; 1989; 10(2):103-8. PubMed ID: 2734547
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Antibodies to Escherichia coli in alcoholic and non-alcoholic patients with cirrhosis of the liver or fatty liver.
    Prytz H; Björneboe M; Orskov F; Hilden M
    Scand J Gastroenterol; 1973; 8(5):433-8. PubMed ID: 4584759
    [No Abstract]   [Full Text] [Related]  

  • 77. Escherichia coli antibodies in alcoholic liver disease. Correlation to alcohol consumption, alcoholic hepatitis, and serum IgA.
    Staun-Olsen P; Bjørneboe M; Prytz H; Thomsen AC; Orskov F
    Scand J Gastroenterol; 1983 Oct; 18(7):889-96. PubMed ID: 6203166
    [TBL] [Abstract][Full Text] [Related]  

  • 78. CA 15-3, mucin-like carcinoma-associated antigen and tissue polypeptide-specific antigen: correlation to disease state and prognosis in breast cancer patients.
    Cohen AD; Gopas J; Karplus G; Cohen Y
    Isr J Med Sci; 1995; 31(2-3):155-9. PubMed ID: 7744585
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Prognostic Value of Preoperative Serum Levels of Five Tumor Markers (Carcinoembryonic Antigen, CA19-9, Alpha-fetoprotein, CA72-4, and CA125) in Gastric Cancer.
    Kim JH; Jun KH; Jung H; Park IS; Chin HM
    Hepatogastroenterology; 2014 May; 61(131):863-9. PubMed ID: 26176088
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Usefulness of a new tumor marker, Span-1, for the diagnosis of pancreatic cancer.
    Kiriyama S; Hayakawa T; Kondo T; Shibata T; Kitagawa M; Ono H; Sakai Y
    Cancer; 1990 Apr; 65(7):1557-61. PubMed ID: 2311067
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.